Injury Prevention Programs in Overhead Athletes
- Conditions
- HealthyShoulder Impingement SyndromeShoulder InjuryShoulder Pain ChronicShoulder Joint LimitationShoulder Flexibility
- Registration Number
- NCT06747702
- Lead Sponsor
- University Ramon Llull
- Brief Summary
To evaluate and describe the effect of performing an integrated injury prevention exercises on the variables considered as injury risk factors in overhead athletes
- Detailed Description
To evaluate and describe the effect of performing fast or 6-8 weeks injury prevention programs on the variables considered as injury risk factors in overhead athletes as glenohumeral rotational range of motion or muscle activation pattern and asymmetries.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Signing the informed consent according last version ogf Helsinky Declaration.
- Be involved in a overhead sport for a minimum of 2 years.
- Have some pain or disconfort to develop the outcome measurements
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Shoulder ROM From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks Shoulder rotational range of movement will be measured made by a single experienced examiner with the IMU Output Capture (Output V2 Unit, Ireland). The IMU will be calibrated prior to ROM testing according to the device instructions. The IMU will be securely attached to the participant's forearm with a self-adhering strap, 10 cm distal to the lateral epicondyle. Measurements will be sent wirelessly to a tablet and subsequently transferred to the Output Hub specific software to calculate ROM
Muscle RMS From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks Escapular complex muscular activation EMG recording will be measured with the mDurance® device (mDurance® Solutions SL, Granada, Spain). The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland). Muscles-activity data were obtained using a validated surface electromyography (EMG) system. This novel system includes a us-er-friendly software, and a light hardware, which make it more affordable and accessible for clinicians and sport trainers. The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland). The unit has a bipolar surface elec-tromyography bipolar sensor for the acquisition of muscle activity. Each Shimmer3 has two channels, with a sampling rate of 1024 Hz applying a bandwidth of 8.4 Hz, and a 24-bit signal with an overall amplification of 100 to10,000 v/v \[41\]. This device is valid and reliable for recording muscle activity during a functional task (ICC = 0.916; 95% CI = 0.831-0.958)
Muscles Asymetries From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks Diferences in % the muscle activation of the interescapular muscle complex by EMG. These recording will be also performed with the mDurance® device (mDurance® Solutions SL, Granada, Spain). The mDurance® system consisted of an EMG Shimmer3 unit (Realtime TechnologiesLtD, Dublin, Ireland) . This device is valid and reliable for recording muscle activity during a functional task (ICC = 0.916
Shoulder proprioception From enrollment to the end of the intervention at 8 weeks. Follow-up at 12-weeks The Ability of recognizing a specific glenohumeral rotational range of movement degrees we will use the IMU Output Capture (Output V2 Unit, Ireland). The IMU was calibrated prior to ROM testing according to the device instructions. The IMU was securely attached to the participant's forearm with a self-adhering strap, 10 cm distal to the lateral epicondyle. Measurements were sent wirelessly to a tablet and subsequently transferred to the Output Hub specific software to calculate ROM
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
FPCEE Blanquerna
🇪🇸Barcelona, Spain